Drug Profile
NCV 01
Alternative Names: NCV-01Latest Information Update: 22 Jan 2015
Price :
$50
*
At a glance
- Originator OncoTherapy Science
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer